Profil
Michael J.
Dawson is currently the Chief of Staff at Centinela Hospital Medical Center.
Previously, he served as the Chief Medical Officer at Leading Biosciences, Inc. and Palisade Bio, Inc. from 2021 to 2022.
He holds a doctorate degree from the University of Southern California and a graduate degree from the University of California San Diego.
Postes actifs de Michael Dawson
| Sociétés | Poste | Début |
|---|---|---|
Centinela Hospital Medical Center
Centinela Hospital Medical Center Hospital/Nursing ManagementHealth Services Operates an acute care hospital | Responsable des Ressources Humaines | - |
Anciens postes connus de Michael Dawson
| Sociétés | Poste | Fin |
|---|---|---|
| PALISADE BIO, INC. | Directeur Technique/Scientifique/R&D | 11/10/2022 |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Directeur Technique/Scientifique/R&D | - |
Formation de Michael Dawson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centinela Hospital Medical Center
Centinela Hospital Medical Center Hospital/Nursing ManagementHealth Services Operates an acute care hospital | Health Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Commercial Services |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
















